Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives
LE Crowley, RA Stockley, DR Thickett… - European …, 2024 - publications.ersnet.org
The shared pathobiological mechanisms driving progressive fibrosis in interstitial lung
diseases (ILDs) remain unclear. Neutrophils, the most common immune cells in the human …
diseases (ILDs) remain unclear. Neutrophils, the most common immune cells in the human …
Diagnosis of fibrotic hypersensitivity pneumonitis: is there a role for biomarkers?
JO Pereira, V Fernandes, TM Alfaro, S Freitas… - Life, 2023 - mdpi.com
Hypersensitivity pneumonitis is a complex interstitial lung syndrome and is associated with
significant morbimortality, particularly for fibrotic disease. This condition is characterized by …
significant morbimortality, particularly for fibrotic disease. This condition is characterized by …
Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a …
T Makiguchi, H Tanaka, K Okudera… - Translational Lung …, 2023 - pmc.ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF) is a risk factor for mortality in patients with
lung cancer. Nintedanib has been known to slow down the decline of lung function and …
lung cancer. Nintedanib has been known to slow down the decline of lung function and …
The Role of HBOT on Pulp Cap** Treatment in Enhancing TGF-β Levels: Sco** Review.
S Sitam, S Pribadi, PY Dewi - Journal of International …, 2022 - search.ebscohost.com
Deep caries could harm the vitality of the pulp, so it is necessary to protect the pulp with pulp
cap** procedure. Pulp cap** material will release growth factors, one of it is TGF-β …
cap** procedure. Pulp cap** material will release growth factors, one of it is TGF-β …
Analysis of drug induced interstitial lung disease in non-small cell lung cancer through modelling and simulation
L Wanika - 2022 - wrap.warwick.ac.uk
A class of drugs known as tyrosine kinase inhibitors (TKIs) are often used in targeted
therapies for the treatment of non-small cell lung cancer (NSCLC). Approximately 1% of non …
therapies for the treatment of non-small cell lung cancer (NSCLC). Approximately 1% of non …